| Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy. | |
| | |
MedLine Citation:
|
PMID: 22483806 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: The role of splenectomy on prophylaxis against hepatitis B virus (HBV) recurrence after liver transplantation (LT) for HBV-related end-stage liver diseases with severe hypersplenism and splenomegaly remains unclear today. METHODS: A total of 510 consecutive patients with HBV-related end-stage liver diseases who underwent LT in Liver Transplantation Center, West China Hospital, Sichuan University (Chengdu, China) between June 1999 and October 2009 were studied retrospectively in this study. Patients were divided into three groups in this study: splenectomized group (group A, n=137), including preoperatively splenectomized subgroup (group A1, n=48) and intraoperatively splenectomized subgroup (group A2, n=89); nonsplenectomized group with severe hypersplenism (group B, n=95); and nonsplenectomized group without severe hypersplenism (group C, n=278). The incidence of posttransplant rejection, posttransplant infection, posttransplant hepatic cell carcinoma recurrence rate, and HBV recurrence rate were recorded. The end of the follow-up period was October 2010. RESULTS: In this study, six patients with HBV recurrence were found in group A, 15 cases in group B, and 13 cases in group C during the follow-up period. (1) The incidence of posttransplant rejection in patients of group A was significantly lower than that in group B (P=0.0023) and also the HBV recurrence rates in group A markedly decreased (P=0.004). (2) The incidence of posttransplant rejection in group A was significantly lower than that in group C (P=0.0433); however, the incidence of posttransplant infection in group A largely increased compared with that in group C (P=0.0233). The HBV recurrence rates between group A and group C had no significant difference (P=0.804). (3) The HBV recurrence rates in group B were significantly higher than that in group C (P=0.001). CONCLUSIONS: The results of this study showed that splenectomy could significantly reduce the incidence of posttransplant rejection and HBV recurrence rate for the patients undergoing LT for HBV-related end-stage liver diseases with severe hypersplenism and splenomegaly. |
| | |
Authors:
|
Yu Zhang; Lunan Yan; Tianfu Wen; Bo Li; Jichun Zhao; Zheyu Chen; Wentao Wang; Mingqing Xu; Jiayin Yang; Yonggang Wei; Yukui Ma; Li Jiang |
Related Documents
:
|
15685516 - A comparison of peritonitis rates from the united states renal data system database: ca... 10873026 - Salvage laparotomy for failure of peritoneal drainage in necrotizing enterocolitis in i... 19540136 - Appetite in chronic hemodialysis patients: a longitudinal study. 2252756 - Influence of phosphatidylcholine on ultrafiltration and solute transfer in capd patients. 22079766 - The relationship between scapular notching and reverse shoulder arthroplasty prosthesis... 16890856 - Compromised bypass graft outcomes after minimal-incision vein harvest. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-16 |
Journal Detail:
|
Title: The Journal of surgical research Volume: - ISSN: 1095-8673 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-4-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0376340 Medline TA: J Surg Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Elsevier Inc. All rights reserved. |
Affiliation:
|
Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China; Division of Transplantation, People's Hospital of Sichuan province, Chengdu, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Formation of septanoses from hexopyranosides via 5,6-exo-glycals.
Next Document: Technetium-99m sestamibi imaging: Are the results dependent on the reviewer?